Summit Global Investments’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,741
Closed -$216K 512
2025
Q4
$216K Buy
+2,741
New +$217K 0.01% 459
2025
Q1
Sell
-167,683
Closed -$13.7M 523
2024
Q4
$13.7M Sell
167,683
-21,829
-12% -$1.82M 0.86% 21
2024
Q3
$15.6M Buy
189,512
+136,723
+259% +$10.2M 1% 16
2024
Q2
$3.71M Buy
52,789
+5,281
+11% +$377K 0.25% 83
2024
Q1
$3.52M Buy
47,508
+11,521
+32% +$803K 0.26% 83
2023
Q4
$2.38M Sell
35,987
-51,267
-59% -$3.21M 0.16% 114
2023
Q3
$5.49M Sell
87,254
-1,951
-2% -$122K 0.37% 57
2023
Q2
$5.04M Buy
89,205
+59,221
+198% +$3.29M 0.33% 78
2023
Q1
$1.74M Buy
+29,984
New +$2.02M 0.13% 152

Other funds holding MET

Summit Global Investments's MET Position: Q1 2026 in Review

Summit Global Investments sold out of MetLife (MET) in Q1 2026, closing a stake of 2,741 shares — an estimated $216K sold.

Summit Global Investments first reported a position in MET in Q1 2023 and held it in 9 quarters. The position peaked at $15.6M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Summit Global Investments reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Summit Global Investments sold 2,741 MetLife shares in Q1 2026, an estimated $216K.
  • Summit Global Investments first reported a position in MetLife in Q1 2023 and held it in 9 quarters.
  • Summit Global Investments's MetLife position peaked at $15.6M in Q3 2024.
  • 1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.